Visalytics
Visalytics
approved EB-2 (NIW)

Research Fellow

Cardiovascular Medicine · Indonesia · 2023-02-27

Processing Time
74 days
Decision Date
2023-02-27
Location
Ohio
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue investigating cardiac metabolism abnormalities in cardiovascular disease to develop novel metabolic interventions and metabolic imaging. The goal is to translate these findings into clinical practice to enhance the capacity of medical institutions to detect heart failure risks.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses heart failure, which affects over 6 million Americans, and is supported by NIH funding.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a Ph.D., 6 years of research experience, and a significant publication record with 488 citations.

3 Waiver Benefit to the US Met

The petitioner's work provides clinical advancements in cardiovascular medicine that outweigh the need for labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's 16 peer-reviewed journal articles (10 as first author) and 488 citations, demonstrating wide recognition in the field. Additional evidence included 24 peer reviews, 6 years of research experience, and funding from the National Institutes of Health (NIH), NWO, and the Netherlands Heart Foundation.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Original Contributions
Government Alignment

Similar Cases

Assistant Professor

Research and Development · India

WeGreened EB-2 (NIW) approved
North Carolina 121 days 2026-01-21
The petitioner proposes to investigate cardiac physiology in the context of heart failure using mouse models to facilitate successful therapeutic interventions for cardiovascular diseases. The work focuses on identifying therapeutic targets and evaluating pharmacological compounds and cell-derived products to improve treatment pathways. This research aims to provide actionable insights into how heart failure develops and progresses to support translational decision-making.
View Case

Postdoctoral Researcher

Research and Development · Bangladesh

WeGreened EB-2 (NIW) approved
Louisiana 63 days 2022-04-13
The petitioner proposes to continue discovering and characterizing molecular receptors, genes, proteins, and cellular pathways that protect cardiomyocytes against heart failure stressors. The work focuses on developing novel treatments for heart failure-inducing pathological stressors such as diabetes, chemotherapy, methamphetamine use, and deleterious genetic mutations.
View Case

Researcher

Biotechnology · Brazil

WeGreened EB-2 (NIW) approved
126 days 2022-03-29
The petitioner proposes to continue her research on cardiovascular disease to facilitate the development of novel treatments and improve existing therapeutic approaches. Her work specifically focuses on elucidating the pathophysiology of cardiovascular diseases to advance next-generation medical interventions.
View Case

Research Assistant

Research and Development · Nepal

WeGreened EB-2 (NIW) approved
Georgia 112 days 2022-03-11
The petitioner proposes to investigate the underlying mechanisms of cardiometabolic issues, including cardiovascular disease, obesity, and diabetes. The work utilizes plant tissue culture and mouse model experimentation to establish improved treatment techniques for cardiovascular patients.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from Indonesia

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-02-27.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 74 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Indonesia All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist